What is a key consideration when monitoring a patient on aminoglycosides?

When monitoring a patient on aminoglycosides, evaluating gait and balance is essential due to the potential for ototoxicity and nephrotoxicity associated with these medications. Aminoglycosides can damage the inner ear structures, resulting in disturbances in balance and coordination. Patients may experience vertigo or dizziness, which could affect their ability to walk steadily.

In clinical practice, it is crucial to assess patients for these neurological side effects, as they can increase the risk of falls and further complications. By carefully monitoring gait and balance, healthcare providers can identify emerging issues early and intervene appropriately, ensuring the patient's safety while on aminoglycoside therapy.